Next Article in Journal
Neuroprotective Properties of Linagliptin: Focus on Biochemical Mechanisms in Cerebral Ischemia, Vascular Dysfunction and Certain Neurodegenerative Diseases
Next Article in Special Issue
Molecular Targets of Aspirin and Prevention of Preeclampsia and Their Potential Association with Circulating Extracellular Vesicles during Pregnancy
Previous Article in Journal
Stereoselective Synthesis and Investigation of Isopulegol-Based Chiral Ligands
Previous Article in Special Issue
Angiogenesis, Lymphangiogenesis, and the Immune Response in South African Preeclamptic Women Receiving HAART
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 20
Issue 16
10.3390/ijms20164051
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Perinatal Micro-Bleeds and Neuroinflammation in E19 Rat Fetuses Exposed to Utero-Placental Ischemia

by
Ashtin B. Giambrone
1,
Omar C. Logue
2,
Qingmei Shao
1,
Gene L. Bidwell III
1,2 and
Junie P. Warrington
1,*
1
Department of Neurology, University of Mississippi Medical Center, Jackson, MS 39216, USA
2
Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, MS 39216, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(16), 4051; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20164051
Submission received: 14 July 2019 / Revised: 15 August 2019 / Accepted: 18 August 2019 / Published: 20 August 2019
(This article belongs to the Special Issue Molecular and Cellular Mechanisms of Preeclampsia)
Browse Figures
Versions Notes

Abstract

:
Offspring of preeclampsia patients have an increased risk of developing neurological deficits and cognitive impairment. While low placental perfusion, common in preeclampsia and growth restriction, has been linked to neurological deficits, a causative link is not fully established. The goal of this study was to test the hypothesis that placental ischemia induces neuroinflammation and micro-hemorrhages in utero. Timed-pregnant Sprague Dawley rats were weight-matched for sham surgery (abdominal incision only) or induced placental ischemia (surgical reduction of utero-placental perfusion (RUPP)); n = 5/group on gestational day 14. Fetal brains (n = 1–2/dam/endpoint) were collected at embryonic day (E19). Placental ischemia resulted in fewer live fetuses, increased fetal demise, increased hematocrit, and no difference in brain water content in exposed fetuses. Additionally, increased cerebral micro-bleeds (identified with H&E staining), pro-inflammatory cytokines: IL-1β, IL-6, and IL-18, eotaxin (CCL11), LIX (CXCL5), and MIP-2 (CXCL2) were observed in RUPP-exposed fetuses. Microglial density in the sub-ventricular zone decreased in RUPP-exposed fetuses, with no change in cortical thickness. Our findings support the hypothesis that exposure to placental ischemia contributes to microvascular dysfunction (increased micro-bleeds), fetal brain inflammation, and reduced microglial density in proliferative brain areas. Future studies will determine whether in utero abnormalities contribute to long-term behavioral deficits in preeclampsia offspring through impaired neurogenesis regulation.

Graphical Abstract

1. Introduction

Preeclampsia (PE), a hypertensive disorder of pregnancy, is characterized by new onset hypertension with proteinuria, or in the absence of proteinuria, symptoms of other organ damage affecting kidney(s), the liver, or the brain [1]. Because PE is associated with increased risk of morbidity and mortality for the mother and offspring, PE contributes significantly to an increased public health burden. There is compelling evidence that exposure to PE has lasting effects on the offspring′s cognitive abilities. Offspring of PE patients go on to have lower IQ scores at 3 years of age [2], have impaired working memory [3], and have other neurobehavioral impairments [4,5] that progressively exacerbate cognitive impairment into the geriatric years [6,7]. Even though the underlying pathophysiological mechanisms are not known, placental insufficiency is believed to play a critical role in these poor neurodevelopmental outcomes [8].
In addition to being the source of the maternal syndrome [9], the dysfunctional placenta fails to meet the metabolic demands of the developing brain [10], resulting in clinical manifestations of neurodevelopmental disorders [11]. Specifically, offspring of PE-complicated pregnancies have a 32% increased risk of autism spectrum disorders [12,13,14]. Moreover, PE is an independent risk factor for long-term neuropsychiatric morbidity in the offspring [15] demonstrating that exposure to maternal factors and/or maternal vascular malperfusion [16] have lasting impacts on learning and memory-function in the offspring. The underlying pathophysiological mechanisms are not fully known.
One potential mechanism could be reduced blood flow to the developing placenta and fetus, a finding in some PE-complicated pregnancies. Indeed, studies report increased expression of hyoxia-inducible factor 1 alpha (HIF-1α) mRNA in placentas from women with preeclampsia [17,18]. The rodent placental ischemia model, induced by surgically reducing utero-placental perfusion pressure (RUPP), is well characterized and shares numerous characteristics with the PE patient. For example, RUPP rats have increased mean arterial blood pressure, with or without proteinuria [19], increased inflammatory cytokines [20,21], and increased anti-angiogenic factors [22,23]. Studies from members of our group have shown that RUPP dams have evidence of cerebrovascular abnormalities [24,25]; however, the impact of placental ischemia on the developing fetal cerebrovasculature has not been investigated. Additionally, whether placental ischemia induces neuroinflammation in the developing brain is not known.
In this study, we induced and modeled placental malperfusion by using the well-established rat model of placental ischemia [26], and determined the effect of five days of ischemia on fetal cerebral micro-bleeds and neuroinflammation. We measured the number of micro-hemorrhages as a marker of micro-bleeds and vascular function, brain water content as a measure of cerebral edema, and cytokine levels and microglia changes to assess neuroinflammation in embryonic day (E19) rat brains.

2. Results

2.1. General Characteristics and Pregnancy Outcomes:

At gestational day (GD) 19, dams (n = 5 per group) subjected to placental ischemia had reduced body weight (266.5 ± 13.5 g) compared to sham-operated (control) pregnant rats (303.1 ± 9.1 g; p = 0.027; Figure 1A).
A key characteristic of placental ischemia, induced using the RUPP procedure, is fetal demise in the form of increased fetal resorptions [19]. We therefore counted the number of live versus resorbed fetuses present at GD 19. Dams subjected to placental ischemia had a trend for fewer live fetuses (7 ± 1 in RUPP group versus 9 ± 1 in the sham control; p = 0.073; Figure 1B) and more fetal resorptions (6 ± 2 in RUPP group versus 1 ± 0 in the sham control; p = 0.021; Figure 1C) compared to the sham controls. This demonstrates that we successfully induced placental ischemia in the dams. We then assessed the effect of placental ischemia on the developing fetus. Because placental ischemia leads to reduced blood flow to the fetal-placental unit, we hypothesized that fetuses would have evidence of systemic hypoxia. We, therefore, measured pups’ hematocrits and found an increase in the hematocrits (36.7% ± 3.0% versus 29.3% ± 2.1% in sham) of fetuses exposed to placental ischemia (p = 0.040; Figure 1D). There was no difference in fetal brain water content between the groups (87.73% ± 0.04% in sham versus 87.73% ± 0.07% in RUPP-exposed; p = 0.485; Figure 1E), suggesting no cerebral edema. Additionally, in this cohort, we found no differences in maternal blood pressure between the groups (98 ± 4 mmHg in sham versus 99 ± 5 mmHg in RUPP; p = 0.405). Thus, our findings are due to utero-placental ischemia, independent of elevated blood pressure.

2.2. Micro-Hemorrhage in Fetal Brains

Using H&E staining, red blood cells can be visualized by their red staining in tissues. Figure 2A shows the location of brain slices used to quantify micro-bleeds. Figure 2B,C show representative micro-bleeds observed in the parenchyma (2B, cortex) and lateral and third ventricles (2C).
We counted the number of micro-bleeds and found significantly higher numbers of micro-hemorrhages in the brains of fetuses exposed to placental ischemia in the posterior sections, and a trend for increased micro-bleeds in the anterior slices of the brain. In the anterior slices, RUPP-exposed fetuses had 3.4 ± 0.8 bleeds compared to the sham-exposed (1.8 ± 0.4 bleeds; p = 0.056; Figure 2D). In the posterior slices, sham-exposed fetuses had 4 ± 1 while RUPP-exposed fetuses had 7 ± 1 bleeds (p = 0.026, Figure 2E). Thus, exposure to placental ischemia almost doubled the incidence of fetal brain micro-bleeds in utero.

2.3. Inflammatory Profile in Fetal Brains

Due to placental ischemia inducing increased maternal, circulating and placental inflammatory cytokines [20,21,27], we hypothesized that the developing fetal brain may mirror the maternal pro-inflammatory environment. We therefore measured the levels of cytokines/chemokines in fetal brains exposed to normal pregnancy and placental ischemia. Out of 27 cytokines and chemokines, seven were undetectable or observed in only 1–2 fetal brains per group: EGF, G-CSF, GM-CSF, GRO/KC, IL-2, IL-5, and IL-13. We divided the remaining 20 cytokines/chemokines into pro-inflammatory/ cytotoxic, anti-inflammatory, and chemokines/growth factors [28]. The pro-inflammatory cytokines IL-1β, IL-6, and IL-18 increased significantly in fetal brains from placental ischemia-exposed pregnancies (Figure 3).
There was a trend toward increased anti-inflammatory cytokines, IL-4 and IL-10. Lastly, the chemokines/growth factors eotaxin (CCL11), LIX/CXCL5, and MIP-2/CXCL2 increased significantly in fetal brains exposed to placental ischemia compared to sham-exposed (Figure 4).
These data demonstrate that placental ischemia exposure induces a pro-inflammatory environment in fetal brains in utero. Whether the cerebral inflammatory profile persists in the postnatal period is unknown. Thus, future studies will determine whether the fetal cerebral pro-inflammatory status is unique to the in utero environment or whether it persists postnatally.
Because micro-hemorrhages are associated with a pro-inflammatory environment [29], we performed correlations to identify whether any factors were strongly associated with the number of micro-bleeds observed. Comparing fetuses from the same dam, we found that cerebral tissue IL-6 levels were positively associated with the number of micro-bleeds detected (Figure 5A; r = 0.673; p = 0.017). Surprisingly, although there were no differences in brain water content between the groups, fetal brain water content was negatively associated with the number of micro-bleeds (Figure 5B; r = −0.672; p = 0.017).

2.4. Microglia Changes in Fetal Brains

Microglia are key producers of cytokines in the brain, so we assessed changes in microglial density and morphology in the brains of exposed fetuses. As reviewed in [30], microglia migrate from the ventricles and meninges during development, making the sub-ventricular zone (SVZ) the ideal region to quantify changes in microglial density. Representative images of a brain section and the third ventricle from sham and placental ischemia-exposed fetuses are shown in Figure 6A, B. We found fewer Iba1 + cells in the SVZ of the third ventricle (40 ± 3 in shams versus 19 ± 4; p = 0.003), and this reduction was observed both in the open (23 ± 2 in sham versus 13 ± 4; p = 0.036) and closed (21 ± 1 in shams versus 9 ± 2; p = 0.005) portion of the third ventricle (Figure 6C). We further characterized the microglia based on morphology into primitive ramified or amoeboid microglia [31] (Figure 6D) and counted these separately. We found a significant decrease in primitive ramified microglia in fetuses exposed to RUPP (13 ± 4 versus 28 ± 2 in Sham, p = 0.007; Figure 6D) and no change in the number of amoeboid microglia (13 ± 4 in Sham versus 5 ± 2 in RUPP, p = 0.089). We found no significant difference in cortical plate thickness (a potential indicator of neuronal density) between the fetuses exposed to normal or placental ischemic pregnancies (Figure 6E,F).

3. Discussion

Offspring born to preeclampsia patients have an increased risk of developing several neurological complications, including neurobehavioral abnormalities, cerebral palsy, cognitive impairment, and perinatal stroke [32,33,34]—the underlying mechanisms of which are not fully known. Here, we tested the hypothesis that utero-placental ischemia leads to in utero cerebrovascular changes, including micro-hemorrhages, which may contribute to future neurological complications. We found that indeed, placental ischemia in the pregnant female rat induces an increased number of cerebral micro-bleeds, a more pro-inflammatory cerebral-tissue environment, and decreased microglial density in the sub-ventricular zone of fetal brains in utero.
Like previous findings, the RUPP procedure led to decreased maternal body weight and increased fetal demise, demonstrating successful induction of placental ischemia [19,35]. Because we did not see an increase in blood pressure in this small cohort of rats, our findings are attributable to placental ischemia, independent of hypertension. We hypothesized that as a result of reduced blood flow to the fetus, surviving fetuses would have evidence of hypoxia. We found significant increases in the hematocrits of fetuses exposed to placental ischemia, suggesting systemic hypoxia. Whether the increased fetal hematocrits were associated with increased angiogenesis through vascular endothelial growth factor (VEGF) in our model is not known. While this possibility cannot be ruled out, our finding of no difference in VEGF levels in the brain homogenates of exposed fetuses suggests that cerebral angiogenesis may not be different between the groups. VEGF also increases vascular permeability and could increase vessel leakage, causing extravasation of plasma proteins. Thus, as a measure of vascular dysfunction, we quantified micro-bleeds within tissue slices.
The incidence of cerebral micro-bleeds was significantly higher in the placental ischemia-exposed group compared to the sham control group. Micro-bleeds are thought to occur when blood vessels are structurally damaged [36]. Thus, an increased incidence of micro-bleeds is consistent with ongoing vascular damage in the brains of exposed fetuses. Cerebral micro-bleeds can lead to long-term neurological damage, including cognitive and motor deficits [36]. Vascular damage and increased blood-brain barrier permeability can result in increases in brain water content; therefore, we hypothesized that fetuses exposed to placental ischemia would have increased cerebral water content, a crude marker of cerebral edema. Contrary to our hypothesis, we found no difference in brain water content between fetuses exposed to normal pregnancy and those exposed to placental ischemia. Even more interesting is the finding of a negative association between the number of cerebral micro-bleeds and brain water content. A recent study reported that micro-bleeds are observed in high-altitude-induced injury long after cerebral edema has resolved [31]. Thus, our finding of no difference in brain water content even in the presence of micro-bleeds could be an indication of a resolution of edema. We do not know whether different fetal or postnatal time-points would yield similar results and this is an area for future investigation. Additionally, we assessed water content in the entire fetal brain and could have missed regional changes in water content as a result.
Maternal inflammation and cerebral micro-bleeds are associated with increases in neuroinflammation. Therefore, we assessed the levels of different cytokines/chemokines in brain homogenates of exposed fetuses. We found increases in the pro-inflammatory cytokines, IL-1β, IL-6, and IL-18, and a trend for increased levels of TNFα and IL-17 in brains of fetuses exposed to placental ischemia. Additionally, IL-10 and IL-4 levels tended to increase in brains of fetuses exposed to placental ischemia. Those data suggest two possibilities. The first possibility is that there is an increased transfer of maternal inflammatory factors across the placental barrier into the fetal circulation. This is plausible since preeclampsia patients have increased circulating levels of tumor necrosis factor alpha (TNFα) [20], interleukin (IL)-2 [37,38], IL-6 [21], and IL-17 [39,40,41]. Placental ischemic rats also have increased levels of inflammatory cytokines in the circulation and cerebrospinal fluid [20,21,27,42,43]. We have not assessed changes in placental barrier permeability in the RUPP model of placental ischemia, and this is an area of ongoing investigation. The second possibility is that there is increased local production of these cytokines in the fetal brains following exposure to placental ischemia.
A key finding in this study is that exposure to placental ischemia leads to increased cerebral levels of the pro-inflammatory cytokine, IL-1β in utero. There is evidence that placentas from preeclampsia patients secrete more IL-1β compared to normotensive placentas [44]. Additionally, infusion of IL-1β into the brains of young rats induces blood-brain barrier breakdown [45]. Taken together, increased tissue levels of IL-1β may play a deleterious role at the blood-brain barrier, contributing to structural damage and subsequent cerebral micro-bleeds. Whether increased IL-1β has a causal role in increased cerebral micro-bleeds in placental ischemia-exposed fetuses will be assessed in future studies.
Our multi-plex cytokine analysis also revealed increased levels of IL-6 and IL-18 in the brains of exposed fetuses. Not only was cerebral IL-6 increased in response to placental ischemia, but fetal brain IL-6 levels positively correlated to the number of cerebral micro-bleeds. Our findings are consistent with reports that serum levels of both IL-6 and IL-18 are higher in patients with cerebral micro-bleeds compared to those without [46]. Another study found that in patients with ischemic cerebrovascular disease, IL-6 was associated with an increased risk for cerebral micro-bleeds in an elderly, community-based cohort [47]. Furthermore, in the developing brain, micro-bleeds were observed in pups exposed to lipopolysaccharide, coupled with intrauterine ischemia, mainly if they were vaginally delivered [48], suggesting that in utero insults make blood vessels more susceptible to injury. Taken together, those studies and our current findings support the hypothesis that maternal inflammation, induced by placental ischemia, contributes to weakened cerebral vessels, making them more susceptible to blood-brain barrier (BBB) disruption and cerebral micro-bleeds.
Previously, we reported that eotaxin (CCL11) is increased in the cerebrospinal fluid of placental ischemic dams [42,49]. In the current study, we found increased levels of eotaxin in the brains of fetuses exposed to placental ischemia. The consequences and source of fetal brain eotaxin levels were not directly investigated in this study, although eotaxin has been shown to promote glutamate-induced neurotoxicity [50]. Importantly, CCL11 has been shown to directly regulate neurogenesis [51], such that increased circulating eotaxin was associated with reduced neurogenesis in aged mice and infusion of CCL11 into young mice resulted in decreased neurogenesis and cognitive impairment. Thus, increased eotaxin levels in the brains of fetuses exposed to placental ischemia suggest that neurogenesis may be impaired.
Microglia are essential during normal brain development and have important roles in pruning synapses, phagocytizing excess neuronal progenitor cells, and regulating the number of neurons at each stage of development [52]. Thus, changes in microglial numbers at late gestation could predict later neurological function. Microglia are also involved in secreting pro-inflammatory cytokines; thus, increased density of microglia could contribute to increases in local tissue inflammation. Following strokes, immune cells (microglia and macrophages) are activated by cytokines and chemokines, and migrate to damaged areas to remove dead neural cells. Those immune cells, induced by a chronic inflammatory environment, may become over-activated and produce large amounts of pro-inflammatory cytokines, disrupting neurogenesis and the BBB [53]. The presence of a pro-inflammatory environment and vascular damage in the brains of fetuses exposed to placental ischemia suggest that microglia may be activated. We therefore hypothesized that brains from exposed fetuses would have an increased density of microglia. Contrary to our hypothesis, we found that placental ischemia exposed fetuses had a decreased density of microglia in the SVZ of the third ventricle. Microglia in that region are vital for neurogenesis and oligodendrogenesis during fetal development and throughout life [52]. Reduced microglial density in the SVZ of placental ischemia-exposed fetuses may predict deficits in neurogenesis and oligodendrogenesis affecting the central nervous system long term. This possibility is a subject of ongoing investigation.
There is evidence that in both rats and mice, microglia protect neonatal brains from injury after ischemic stroke, and that depletion of microglia led to worse outcomes [54]. Thus, increased cerebral micro-hemorrhages, as occurred in exposed fetuses, coupled with fewer microglia, may indicate more severe damage/outcomes. During development, microglia can be disturbed by cytokines and chemokines released under conditions of maternal inflammation [55] seen in placental ischemia.
To our knowledge, this is the first study reporting the impact of placental ischemia on cerebral micro-bleed incidence and neuroinflammation in the offspring in utero. The inclusion of male and female offspring in all analyses is a strength of the current study; however, we were unable to assess sex differences in our endpoints. Ongoing and future studies are now utilizing genotyping for sex to specifically assess sex differences. Additionally, this study utilized only one time-point (E19) and we are therefore unable to extend our findings to the postnatal period. Because we used brain homogenates to assess the inflammatory status, we were unable to address regional changes in expression of the different cytokines, chemokines, and growth factors assessed. We limited our microglial analysis to the SVZ associated with the third ventricle for this study; however, analysis of microglial changes in other brain regions will be important.
In conclusion, the rat placental ischemia model induces increased cerebral micro-hemorrhages in the developing brain in utero and may be a good model to assess the etiology of cerebral micro-hemorrhages associated with preeclampsia-complicated pregnancies. Our data suggest that a hypoxic environment in the fetus, induced by reducing maternal utero-placental perfusion, induces abnormalities in cerebrovascular structure, increased blood-brain barrier disruption and micro-bleeds in the developing fetal brain. This is associated with a pro-inflammatory environment and reduced microglial density in proliferative brain regions, and may underlie the increased neurodevelopmental abnormalities observed in offspring born to preeclampsia patients. Additional studies are required to elucidate the underlying causes of these observations and to establish whether there are time-dependent differences in the outcome measures.

4. Materials and Methods

4.1. Animals

Female timed-pregnant Sprague Dawley rats were obtained from Harlan Laboratories and arrived on gestational day (GD) 11. For timed pregnant rats from Harlan Laboratories, the day of vaginal plug detection was considered gestational day 0. Pregnant rats were housed singly after surgery (GD 14) and had continuous access to standard rodent chow and tap water. One to two (1–2) fetuses per dam per endpoint were randomly selected at E19 from 5 dams per group. Both male and female fetuses were included in all analyses; however, the sex of individual fetuses was not determined. Rats were maintained on a 12 h light and 12 h dark cycle. All animal procedures were approved by the University of Mississippi Medical Center’s Institutional Animal Care and Use Committee before animal procedures commenced (1379A, June 16 2016).

4.2. Placental Ischemia Induction

On GD 14, rats were anesthetized using isoflurane and an abdominal incision was made. The utero-placental unit was exteriorized and a silver clip (0.203 mm) was placed on the abdominal aorta (below the kidneys and above the bifurcation). Silver clips (0.1 mm) were also placed on both uterine artery branches between the ovaries and the first pup. This procedure induces placental ischemia by reducing utero-placental perfusion pressure (RUPP). Pregnant rats in the sham group were treated similarly, in that, an abdominal incision was made, the uterine horn was exteriorized, and vessels were manipulated without clip placement. Carprofen (5 mg/kg) was used as an analgesic in both groups.

4.3. Carotid Surgery and Blood Pressure Measurement

On GD18, rats were anesthetized using isoflurane anesthesia and the left carotid artery was isolated and cannulated using pre-made saline-filled catheters. Catheters were secured and exteriorized at the nape of the neck. The incision was closed and secured using Vetbond. The following morning, rats were placed in restrainer cages and catheters were connected to a pressure transducer. After 30 min of acclimation, blood pressure was recorded for 30 min using LabChart software. The mean arterial pressure was calculated for the duration of 30 min.

4.4. Harvest and Collection of Tissues

On GD 19, pregnant rats were anesthetized using isoflurane, and an abdominal incision was made. After exteriorization of the fetal-placental unit, maternal blood was collected from the abdominal aorta. Dams were euthanized by removal of the heart. The number of live and resorbed pups were counted. Fetuses were euthanized by decapitation. Trunk blood was collected from fetuses using micro-capillary tubes and hematocrit was noted. Fetal heads were processed differently depending on endpoints. For brain water content, brains were removed, weighed, and then dried for 48 h at 60 °C. Brain water content was calculated as a percentage ((wet weight − dry weight)/ wet weight). Brains for molecular analyses were removed and flash frozen in liquid nitrogen, followed by storage in a −80 °C freezer until processing. Brains for immunofluorescence staining or histology were kept within the skull and placed in 4% paraformaldehyde at 4 °C overnight. The following day, brains were removed from the skull and placed back in 4% paraformaldehyde overnight. Brains were then transferred to a 30% sucrose solution at 4 °C for 72 h and then embedded in Cryogel, and frozen at −80 °C until sectioning (1–2 fetal brains per mold). Brains were sectioned at 20 µm thickness, transferred directly to slides, and stored at −20 °C until staining.

4.5. Micro-Bleed Detection

Slides were washed and stained using hematoxylin and eosin following the manufacturer’s directions. Slides were then cover-slipped and imaged using light microscopy. Micro-bleeds were identified as red cells within the parenchyma and outside of the blood vessel lumen or within the ventricles. Micro-bleeds were counted by an investigator blinded to the groups (ABG) in sections from the anterior and posterior part of the brain (Figure 2A). The number of micro-bleeds from two slices per region was averaged per fetus and further averaged per dam.

4.6. Fetal Brain Multiplex Array

To determine the cerebral inflammatory profile of exposed fetuses, a separate group of brains (n = 1 pup per dam) were homogenized in RIPA buffer, and protein concentration was measured using the BCA kit. Equal volumes (25 µL) of sample were loaded into 96 well-plates and incubated with magnetic beads, pre-mixed to detect 27 cytokine/chemokines (Rat multiplex kit, Millipore Sigma, Burlington, MA, USA). Samples were run alongside standards and kit controls in duplicate. The observed concentration was calculated using the standard curve generated and normalized to the protein concentration of the sample. Cytokine/chemokine concentration is, therefore, presented as pg/mg protein.

4.7. Analysis of Microglia

Slides were washed and then blocked using normal donkey serum followed by rabbit anti-Iba1 polyclonal antibody (1:500; Wako; 019-19741) overnight at 4 °C. This Iba1 antibody recognizes the carboxy-terminal of the Iba1 protein and is specific to microglia/macrophages. Slides were washed and incubated for 2 h in donkey anti-rabbit TRITC (JacksonImmuno, West Grove, PA, USA; 131591) at room temperature. After washing, slides were mounted using Vectashield Mounting Media with DAPI and placed on coverslips. Images were captured using confocal microscopy with a 40X objective. Iba1+ cells were counted in the sub-ventricular zones (SVZ) associated with the third ventricle. A total of 2 sections per fetus were used for microglial assessment. Images of the third ventricle’s open and closed regions were captured from each fetal brain. Microglia totals from 1–2 pups were averaged per dam. Counting was done in a blind fashion. At E19, microglia have a different morphology from those in the adult brain; and amoeboid and primitive ramified microglia are most commonly observed [31]. We therefore counted the number of amoeboid and primitive ramified microglia in the SVZ. Image analysis was done using ImageJ (version 1.51j8; NIH). Cortical images were captured using a 10X objective, and the thickness of the cortical plate was analyzed using NIS Elements’ Analysis software (Nikon Instruments Inc., Melville, NY, USA; version 5.10.01). A total of 6 measurements per pup brain were obtained within the cortical plate and averaged per pup, and further averaged per dam.

4.8. Statistical Analysis

All statistical analyses were conducted using GraphPad Prism software (version 7). Differences between the sham-exposed and placental ischemia-exposed dams and fetuses were calculated using unpaired t-tests. For analyses where variances were different, we used Welch’s t-test with corrections for unequal variance. Pearson’s correlations were calculated to determine the association between various factors. Outlier tests (ROUT, Q = 1%) were conducted when visible outliers were suspected. For the microglia density data, two outliers (fetuses from the same dam from the sham-exposed group) were removed from analysis and are not shown. All graphs depict values for individual animals along with the mean ± SEM. The threshold for statistical difference was set at p < 0.05.

5. Conclusions

Placental ischemia, a common finding in preeclampsia-complicated pregnancies, leads to increased pro-inflammatory cytokines, increased micro-bleeds, and reduced microglia in proliferative zones of E19 fetal brains. Thus, our findings support the hypothesis that neuroinflammation, micro-vascular damage, and impaired microglia function may partly explain cognitive deficits that occur in offspring of preeclamptic pregnancies.

Author Contributions

Study design, J.P.W., G.L.B., and O.C.L.; collection of data, J.P.W., O.C.L., Q.S., and A.B.G.; drafting the manuscript, A.B.G. and J.P.W.; critically reviewing the manuscript, J.P.W., A.B.G., and G.L.B.; approving the final draft of manuscript A.B.G, O.C.L., Q.S., G.L.B., and J.P.W..

Funding

This research was funded by a COBRE pilot grant from the National Institutes of Health (P20GM104357) and a K99/R00 award to JPW (HL129192). Fluorescence images were captured using a confocal microscope from the Imaging Core, funded through an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the NIH, under grant number P30GM103328. The APC was funded by NIH HL129192.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Abbreviations

PEPreeclampsia
RUPPReduced Uterine Perfusion Pressure
SVZSub-ventricular zone
GDGestational day
BBBBlood-brain barrier

References

  1. Roberts, J.M.; August, P.A.; Bakris, G.; Barton, J.R.; Bernstein, I.M.; Druzin, M.; Gaiser, R.R.; Granger, J.P.; Jeyabalan, A.; Johnson, D.D.; et al. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obs. Gynecol 2013, 122, 1122–1131. [Google Scholar] [CrossRef]
  2. Many, A.; Fattal, A.; Leitner, Y.; Kupferminc, M.J.; Harel, S.; Jaffa, A. Neurodevelopmental and cognitive assessment of children born growth restricted to mothers with and without preeclampsia. Hypertens Pregnancy 2003, 22, 25–29. [Google Scholar] [CrossRef] [PubMed]
  3. Rätsep, M.T.; Hickman, A.F.; Maser, B.; Pudwell, J.; Smith, G.N.; Brien, D.; Stroman, P.W.; Adams, M.A.; Reynolds, J.N.; Croy, B.A.; et al. Impact of preeclampsia on cognitive function in the offspring. Behav. Brain Res. 2016, 302, 175–181. [Google Scholar] [CrossRef] [PubMed]
  4. Muñoz-Moreno, E.; Fischi-Gomez, E.; Batalle, D.; Borradori-Tolsa, C.; Eixarch, E.; Thiran, J.P.; Gratacós, E.; Hüppi, P.S. Structural Brain Network Reorganization and Social Cognition Related to Adverse Perinatal Condition from Infancy to Early Adolescence. Front. Neurosci. 2016, 10, 560. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Chen, J.; Chen, P.; Bo, T.; Luo, K. Cognitive and Behavioral Outcomes of Intrauterine Growth Restriction School-Age Children. Pediatrics 2016, 137. [Google Scholar] [CrossRef] [PubMed]
  6. Tuovinen, S.; Aalto-Viljakainen, T.; Eriksson, J.G.; Kajantie, E.; Lahti, J.; Pesonen, A.K.; Heinonen, K.; Lahti, M.; Osmond, C.; Barker, D.J.; et al. Maternal hypertensive disorders during pregnancy: Adaptive functioning and psychiatric and psychological problems of the older offspring. BJOG 2014, 121, 1482–1491. [Google Scholar] [CrossRef] [PubMed]
  7. Raikkonen, K.; Kajantie, E.; Pesonen, A.K.; Heinonen, K.; Alastalo, H.; Leskinen, J.T.; Nyman, K.; Henriksson, M.; Lahti, J.; Lahti, M.; et al. Early life origins cognitive decline: Findings in elderly men in the Helsinki Birth Cohort Study. PLoS ONE 2013, 8, e54707. [Google Scholar] [CrossRef] [PubMed]
  8. Kaukola, T.; Räsänen, J.; Herva, R.; Patel, D.D.; Hallman, M. Suboptimal neurodevelopment in very preterm infants is related to fetal cardiovascular compromise in placental insufficiency. Am. J. Obs. Gynecol. 2005, 193, 414–420. [Google Scholar] [CrossRef]
  9. Chaiworapongsa, T.; Chaemsaithong, P.; Yeo, L.; Romero, R. Pre-eclampsia part 1: Current understanding of its pathophysiology. Nat. Rev. Nephrol. 2014, 10, 466–480. [Google Scholar] [CrossRef]
  10. Lo, J.O.; Roberts, V.H.J.; Schabel, M.C.; Wang, X.; Morgan, T.K.; Liu, Z.; Studholme, C.; Kroenke, C.D.; Frias, A.E. Novel Detection of Placental Insufficiency by Magnetic Resonance Imaging in the Nonhuman Primate. Reprod. Sci. 2018, 25, 64–73. [Google Scholar] [CrossRef]
  11. Maher, G.M.; O'Keeffe, G.W.; Kearney, P.M.; Kenny, L.C.; Dinan, T.G.; Mattsson, M.; Khashan, A.S. Association of Hypertensive Disorders of Pregnancy With Risk of Neurodevelopmental Disorders in Offspring: A Systematic Review and Meta-analysis. Jama Psychiatry 2018, 75, 809–819. [Google Scholar] [CrossRef] [PubMed]
  12. Dachew, B.A.; Mamun, A.; Maravilla, J.C.; Alati, R. Pre-eclampsia and the risk of autism-spectrum disorder in offspring: Meta-analysis. Br. J. Psychiatry 2018, 212, 142–147. [Google Scholar] [CrossRef] [PubMed]
  13. Walker, C.K.; Krakowiak, P.; Baker, A.; Hansen, R.L.; Ozonoff, S.; Hertz-Picciotto, I. Preeclampsia, placental insufficiency, and autism spectrum disorder or developmental delay. Jama Pediatr 2015, 169, 154–162. [Google Scholar] [CrossRef] [PubMed]
  14. Curran, E.A.; O'Keeffe, G.W.; Looney, A.M.; Moloney, G.; Hegarty, S.V.; Murray, D.M.; Khashan, A.S.; Kenny, L.C. Exposure to Hypertensive Disorders of Pregnancy Increases the Risk of Autism Spectrum Disorder in Affected Offspring. Mol. Neurobiol 2018, 55, 5557–5564. [Google Scholar] [CrossRef] [PubMed]
  15. Nahum Sacks, K.; Friger, M.; Shoham-Vardi, I.; Sergienko, R.; Spiegel, E.; Landau, D.; Sheiner, E. Long-term neuropsychiatric morbidity in children exposed prenatally to preeclampsia. Early Hum. Dev. 2019, 130, 96–100. [Google Scholar] [CrossRef]
  16. Parks, W.T. Manifestations of Hypoxia in the Second and Third Trimester Placenta. Birth Defects Res. 2017, 109, 1345–1357. [Google Scholar] [CrossRef] [PubMed]
  17. Harati-Sadegh, M.; Kohan, L.; Teimoori, B.; Mehrabani, M.; Salimi, S. The association of the placental Hypoxia-inducible factor1-alpha polymorphisms and HIF1-alpha mRNA expression with preeclampsia. Placenta 2018, 67, 31–37. [Google Scholar] [CrossRef]
  18. Wang, S.; Wang, X.; Weng, Z.; Zhang, S.; Ning, H.; Li, B. Expression and role of microRNA 18b and hypoxia inducible factor-1alpha in placental tissues of preeclampsia patients. Exp. Med. 2017, 14, 4554–4560. [Google Scholar] [CrossRef]
  19. Alexander, B.T.; Kassab, S.E.; Miller, M.T.; Abram, S.R.; Reckelhoff, J.F.; Bennett, W.A.; Granger, J.P. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 2001, 37, 1191–1195. [Google Scholar] [CrossRef]
  20. LaMarca, B.B.; Bennett, W.A.; Alexander, B.T.; Cockrell, K.; Granger, J.P. Hypertension produced by reductions in uterine perfusion in the pregnant rat: Role of tumor necrosis factor-alpha. Hypertension 2005, 46, 1022–1025. [Google Scholar] [CrossRef]
  21. Gadonski, G.; LaMarca, B.B.; Sullivan, E.; Bennett, W.; Chandler, D.; Granger, J.P. Hypertension produced by reductions in uterine perfusion in the pregnant rat: Role of interleukin 6. Hypertension 2006, 48, 711–716. [Google Scholar] [CrossRef]
  22. Gilbert, J.S.; Gilbert, S.A.; Arany, M.; Granger, J.P. Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension 2009, 53, 399–403. [Google Scholar] [CrossRef]
  23. Gilbert, J.S.; Babcock, S.A.; Granger, J.P. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 2007, 50, 1142–1147. [Google Scholar] [CrossRef]
  24. Warrington, J.P.; Fan, F.; Murphy, S.R.; Roman, R.J.; Drummond, H.A.; Granger, J.P.; Ryan, M.J. Placental ischemia in pregnant rats impairs cerebral blood flow autoregulation and increases blood-brain barrier permeability. Physiol. Rep. 2014, 2. [Google Scholar] [CrossRef]
  25. Warrington, J.P.; Drummond, H.A.; Granger, J.P.; Ryan, M.J. Placental Ischemia-induced Increases in Brain Water Content and Cerebrovascular Permeability: Role of TNFα. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2015, 309, R1425–R1431. [Google Scholar] [CrossRef]
  26. Granger, J.P.; LaMarca, B.B.; Cockrell, K.; Sedeek, M.; Balzi, C.; Chandler, D.; Bennett, W. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol. Med. 2006, 122, 383–392. [Google Scholar]
  27. LaMarca, B.; Wallukat, G.; Llinas, M.; Herse, F.; Dechend, R.; Granger, J.P. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension 2008, 52, 1168–1172. [Google Scholar] [CrossRef]
  28. Chhor, V.; Moretti, R.; Le Charpentier, T.; Sigaut, S.; Lebon, S.; Schwendimann, L.; Oré, M.V.; Zuiani, C.; Milan, V.; Josserand, J.; et al. Role of microglia in a mouse model of paediatric traumatic brain injury. Brain Behav. Immun. 2017, 63, 197–209. [Google Scholar] [CrossRef]
  29. Ahn, S.J.; Anrather, J.; Nishimura, N.; Schaffer, C.B. Diverse Inflammatory Response After Cerebral Microbleeds Includes Coordinated Microglial Migration and Proliferation. Stroke 2018, 49, 1719–1726. [Google Scholar] [CrossRef]
  30. Menassa, D.A.; Gomez-Nicola, D. Microglial Dynamics During Human Brain Development. Front. Immunol. 2018, 9, 1014. [Google Scholar] [CrossRef] [Green Version]
  31. Dalmau, I.; Finsen, B.; Tønder, N.; Zimmer, J.; González, B.; Castellano, B. Development of microglia in the prenatal rat hippocampus. J. Comp. Neurol. 1997, 377, 70–84. [Google Scholar] [CrossRef]
  32. Luo, L.; Chen, D.; Qu, Y.; Wu, J.; Li, X.; Mu, D. Association between hypoxia and perinatal arterial ischemic stroke: A meta-analysis. PLoS ONE 2014, 9, e90106. [Google Scholar] [CrossRef]
  33. Lee, J.; Croen, L.A.; Backstrand, K.H.; Yoshida, C.K.; Henning, L.H.; Lindan, C.; Ferriero, D.M.; Fullerton, H.J.; Barkovich, A.J.; Wu, Y.W. Maternal and infant characteristics associated with perinatal arterial stroke in the infant. JAMA 2005, 293, 723–729. [Google Scholar] [CrossRef]
  34. Wu, Y.W.; March, W.M.; Croen, L.A.; Grether, J.K.; Escobar, G.J.; Newman, T.B. Perinatal stroke in children with motor impairment: A population-based study. Pediatrics 2004, 114, 612–619. [Google Scholar] [CrossRef]
  35. Li, J.; Lamarca, B.; Reckelhoff, J.F. A Model of Pre-eclampsia in Rats: The Reduced Uterine Perfusion Pressure (RUPP) Model. Am. J. Physiol. Heart Circ. Physiol. 2012, 303, H1–H8. [Google Scholar]
  36. Martinez-Ramirez, S.; Greenberg, S.M.; Viswanathan, A. Cerebral microbleeds: Overview and implications in cognitive impairment. Alzheimers Res. 2014, 6, 33. [Google Scholar] [CrossRef]
  37. Molvarec, A.; Szarka, A.; Walentin, S.; Beko, G.; Karádi, I.; Prohászka, Z.; Rigó, J. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia. Reprod. Biol. Endocrinol. 2011, 9, 124. [Google Scholar] [CrossRef]
  38. Szarka, A.; Rigó, J.; Lázár, L.; Beko, G.; Molvarec, A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 2010, 11, 59. [Google Scholar] [CrossRef]
  39. Darmochwal-Kolarz, D.; Kludka-Sternik, M.; Tabarkiewicz, J.; Kolarz, B.; Rolinski, J.; Leszczynska-Gorzelak, B.; Oleszczuk, J. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J. Reprod. Immunol. 2012, 93, 75–81. [Google Scholar] [CrossRef]
  40. Toldi, G.; Rigó, J.; Stenczer, B.; Vásárhelyi, B.; Molvarec, A. Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia. Am. J. Reprod. Immunol. 2011, 66, 223–229. [Google Scholar] [CrossRef]
  41. Martínez-García, E.A.; Chávez-Robles, B.; Sánchez-Hernández, P.E.; Núñez-Atahualpa, L.; Martín-Máquez, B.T.; Muñoz-Gómez, A.; González-López, L.; Gámez-Nava, J.I.; Salazar-Páramo, M.; Dávalos-Rodríguez, I.; et al. IL-17 increased in the third trimester in healthy women with term labor. Am. J. Reprod. Immunol. 2011, 65, 99–103. [Google Scholar] [CrossRef]
  42. Warrington, J.P. Placental ischemia increases seizure susceptibility and cerebrospinal fluid cytokines. Physiol. Rep. 2015, 3. [Google Scholar] [CrossRef]
  43. LaMarca, B.B.; Cockrell, K.; Sullivan, E.; Bennett, W.; Granger, J.P. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension 2005, 46, 82–86. [Google Scholar] [CrossRef]
  44. Amash, A.; Holcberg, G.; Sapir, O.; Huleihel, M. Placental secretion of interleukin-1 and interleukin-1 receptor antagonist in preeclampsia: Effect of magnesium sulfate. J. Interferon Cytokine Res. 2012, 32, 432–441. [Google Scholar] [CrossRef]
  45. Anthony, D.; Dempster, R.; Fearn, S.; Clements, J.; Wells, G.; Perry, V.H.; Walker, K. CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown. Curr. Biol. 1998, 8, 923–926. [Google Scholar] [CrossRef]
  46. Miwa, K.; Tanaka, M.; Okazaki, S.; Furukado, S.; Sakaguchi, M.; Kitagawa, K. Relations of blood inflammatory marker levels with cerebral microbleeds. Stroke 2011, 42, 3202–3206. [Google Scholar] [CrossRef]
  47. Gu, Y.; Gutierrez, J.; Meier, I.B.; Guzman, V.A.; Manly, J.J.; Schupf, N.; Brickman, A.M.; Mayeux, R. Circulating inflammatory biomarkers are related to cerebrovascular disease in older adults. Neurol. Neuroimmunol. Neuroinflamm. 2019, 6, e521. [Google Scholar] [CrossRef]
  48. Theriault, B.C.; Woo, S.K.; Karimy, J.K.; Keledjian, K.; Stokum, J.A.; Sarkar, A.; Coksaygan, T.; Ivanova, S.; Gerzanich, V.; Simard, J.M. Cerebral microbleeds in a neonatal rat model. PLoS ONE 2017, 12, e0171163. [Google Scholar] [CrossRef]
  49. Zhang, L.W.; Warrington, J.P. Magnesium Sulfate Prevents Placental Ischemia-Induced Increases in Brain Water Content and Cerebrospinal Fluid Cytokines in Pregnant Rats. Front. Neurosci. 2016, 10, 561. [Google Scholar] [CrossRef]
  50. Parajuli, B.; Horiuchi, H.; Mizuno, T.; Takeuchi, H.; Suzumura, A. CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia. Glia 2015, 63, 2274–2284. [Google Scholar] [CrossRef]
  51. Villeda, S.A.; Luo, J.; Mosher, K.I.; Zou, B.; Britschgi, M.; Bieri, G.; Stan, T.M.; Fainberg, N.; Ding, Z.; Eggel, A.; et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 2011, 477, 90–94. [Google Scholar] [CrossRef] [Green Version]
  52. Shigemoto-Mogami, Y.; Hoshikawa, K.; Goldman, J.E.; Sekino, Y.; Sato, K. Microglia enhance neurogenesis and oligodendrogenesis in the early postnatal subventricular zone. J. Neurosci. 2014, 34, 2231–2243. [Google Scholar] [CrossRef]
  53. Xiong, X.Y.; Liu, L.; Yang, Q.W. Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke. Prog. Neurobiol. 2016, 142, 23–44. [Google Scholar] [CrossRef]
  54. Fernández-López, D.; Faustino, J.; Klibanov, A.L.; Derugin, N.; Blanchard, E.; Simon, F.; Leib, S.L.; Vexler, Z.S. Microglial Cells Prevent Hemorrhage in Neonatal Focal Arterial Stroke. J. Neurosci. 2016, 36, 2881–2893. [Google Scholar] [CrossRef] [Green Version]
  55. Thion, M.S.; Ginhoux, F.; Garel, S. Microglia and early brain development: An intimate journey. Science 2018, 362, 185–189. [Google Scholar] [CrossRef] [Green Version]
Ijms 20 04051 g001 550
Figure 1. General characteristics of dams and fetuses subjected to placental ischemia. Dams had (A) reduced body weight, (B) reduced numbers of live fetuses, and (C) increased fetal demise at gestational day (GD) 19 compared to the sham controls. Fetuses subjected to placental ischemia had (D) increased hematocrits and (E) no change in brain water content. Values for individual rats (n = 5 dams per group) are shown along with the Mean ± SEM. Fetal hematocrit and pup brain water content represent the mean of 1–2 pups/dam (n = 5 dams). Differences between groups were analyzed using an unpaired t-test.
Figure 1. General characteristics of dams and fetuses subjected to placental ischemia. Dams had (A) reduced body weight, (B) reduced numbers of live fetuses, and (C) increased fetal demise at gestational day (GD) 19 compared to the sham controls. Fetuses subjected to placental ischemia had (D) increased hematocrits and (E) no change in brain water content. Values for individual rats (n = 5 dams per group) are shown along with the Mean ± SEM. Fetal hematocrit and pup brain water content represent the mean of 1–2 pups/dam (n = 5 dams). Differences between groups were analyzed using an unpaired t-test.
Ijms 20 04051 g001
Ijms 20 04051 g002 550
Figure 2. Placental ischemia exposure leads to increased number of micro-bleeds in brains of exposed fetuses. (A) Schematic of the regions where coronal sections were collected. (B) Representative images of fetal brains showing micro-bleeds in the cortex and (C) ventricles. Number of micro-bleeds in the (D) anterior (E) posterior slices of fetal brains. Points represent average micro-bleeds from 1–2 pups per dam (n = 5 dams per group). Mean ± SEM is also depicted. Data were analyzed using unpaired t-test and p-values are indicated.
Figure 2. Placental ischemia exposure leads to increased number of micro-bleeds in brains of exposed fetuses. (A) Schematic of the regions where coronal sections were collected. (B) Representative images of fetal brains showing micro-bleeds in the cortex and (C) ventricles. Number of micro-bleeds in the (D) anterior (E) posterior slices of fetal brains. Points represent average micro-bleeds from 1–2 pups per dam (n = 5 dams per group). Mean ± SEM is also depicted. Data were analyzed using unpaired t-test and p-values are indicated.
Ijms 20 04051 g002
Ijms 20 04051 g003 550
Figure 3. Placental ischemia leads to a shift towards a pro-inflammatory status in brains of exposed fetuses. A rat multiplex kit array of 27 cytokine/chemokine was used. Values were normalized to protein concentration. IL-1β, IL-6, and IL-18 increased significantly in fetal brains exposed to placental ischemia. Blue points represent extrapolated values (one value below the lowest detectable value and normalized to protein concentration). Not shown are: IL-2, IL-5, and IL-13. Values for individual rat fetuses (n = 5 fetuses per group) are shown along with the mean ± SEM. Only one fetal brain was collected per dam for cytokines/chemokines.
Figure 3. Placental ischemia leads to a shift towards a pro-inflammatory status in brains of exposed fetuses. A rat multiplex kit array of 27 cytokine/chemokine was used. Values were normalized to protein concentration. IL-1β, IL-6, and IL-18 increased significantly in fetal brains exposed to placental ischemia. Blue points represent extrapolated values (one value below the lowest detectable value and normalized to protein concentration). Not shown are: IL-2, IL-5, and IL-13. Values for individual rat fetuses (n = 5 fetuses per group) are shown along with the mean ± SEM. Only one fetal brain was collected per dam for cytokines/chemokines.
Ijms 20 04051 g003
Ijms 20 04051 g004 550
Figure 4. Changes in chemokines/growth factors in fetal brains. Placental ischemia exposure increased eotaxin, LIX, and MIP2 levels. Not shown are: EGF, G-CSF, GM-CSF, and GRO/KC. Blue points represent extrapolated values (one value below lowest detectable value and normalized to protein concentration). Values for individual fetuses (n = 5 fetuses per group) are shown along with the mean ± SEM. Data were analyzed using unpaired t-tests, and p-values are indicated.
Figure 4. Changes in chemokines/growth factors in fetal brains. Placental ischemia exposure increased eotaxin, LIX, and MIP2 levels. Not shown are: EGF, G-CSF, GM-CSF, and GRO/KC. Blue points represent extrapolated values (one value below lowest detectable value and normalized to protein concentration). Values for individual fetuses (n = 5 fetuses per group) are shown along with the mean ± SEM. Data were analyzed using unpaired t-tests, and p-values are indicated.
Ijms 20 04051 g004
Ijms 20 04051 g005 550
Figure 5. Correlation between number of micro-bleeds and IL-6 levels or brain water content. The number of micro-bleeds is (A) positively associated with fetal brain IL-6 levels and (B) negatively associated with fetal brain water content. Fetuses from same dam were used for the association analysis. Values for individual rats (n = 5 fetuses per group) are shown. Relationships between factors were analyzed using the Pearson correlation.
Figure 5. Correlation between number of micro-bleeds and IL-6 levels or brain water content. The number of micro-bleeds is (A) positively associated with fetal brain IL-6 levels and (B) negatively associated with fetal brain water content. Fetuses from same dam were used for the association analysis. Values for individual rats (n = 5 fetuses per group) are shown. Relationships between factors were analyzed using the Pearson correlation.
Ijms 20 04051 g005
Ijms 20 04051 g006 550
Figure 6. Changes in microglia at the proliferative areas (sub-ventricular zones—SVZ) of the 3rd Ventricle. (A) Representative image showing, at the brain-level, the section where the microglial analysis was conducted. Scale bar = 100 µm. (B) Representative images of Iba1 staining in the open region and closed region of the 3rd ventricle. Red—Iba1+ cells; Blue—DAPI+ nuclei. Scale bar represents 50 µm. (C) Decreased number of microglia in the SVZ of pups exposed to placental ischemia. (D) Examples of different microglia types observed (scale bar = 20 µm) and quantification of primitive ramified and amoeboid microglia in SVZ. (E) Representative images showing the different cortical layers in the embryonic day (E19) pup brain. Scale bar represents 100 µm. (F) Quantification of cortical plate thickness in fetuses exposed to sham or placental ischemia. Values from 1–2 pups were averaged per dam (n = 4–5 per group) and shown along with the mean ± SEM. Data were analyzed using unpaired t-tests, and p-values are indicated. MZ—marginal zone, CP—cortical plate, SP—subcortical plate, SVZ—sub-ventricular zone, VZ—ventricular zone, and LV—lateral ventricle.
Figure 6. Changes in microglia at the proliferative areas (sub-ventricular zones—SVZ) of the 3rd Ventricle. (A) Representative image showing, at the brain-level, the section where the microglial analysis was conducted. Scale bar = 100 µm. (B) Representative images of Iba1 staining in the open region and closed region of the 3rd ventricle. Red—Iba1+ cells; Blue—DAPI+ nuclei. Scale bar represents 50 µm. (C) Decreased number of microglia in the SVZ of pups exposed to placental ischemia. (D) Examples of different microglia types observed (scale bar = 20 µm) and quantification of primitive ramified and amoeboid microglia in SVZ. (E) Representative images showing the different cortical layers in the embryonic day (E19) pup brain. Scale bar represents 100 µm. (F) Quantification of cortical plate thickness in fetuses exposed to sham or placental ischemia. Values from 1–2 pups were averaged per dam (n = 4–5 per group) and shown along with the mean ± SEM. Data were analyzed using unpaired t-tests, and p-values are indicated. MZ—marginal zone, CP—cortical plate, SP—subcortical plate, SVZ—sub-ventricular zone, VZ—ventricular zone, and LV—lateral ventricle.
Ijms 20 04051 g006

Share and Cite

MDPI and ACS Style

Giambrone, A.B.; Logue, O.C.; Shao, Q.; Bidwell, G.L., III; Warrington, J.P. Perinatal Micro-Bleeds and Neuroinflammation in E19 Rat Fetuses Exposed to Utero-Placental Ischemia. Int. J. Mol. Sci. 2019, 20, 4051. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20164051

AMA Style

Giambrone AB, Logue OC, Shao Q, Bidwell GL III, Warrington JP. Perinatal Micro-Bleeds and Neuroinflammation in E19 Rat Fetuses Exposed to Utero-Placental Ischemia. International Journal of Molecular Sciences. 2019; 20(16):4051. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20164051

Chicago/Turabian Style

Giambrone, Ashtin B., Omar C. Logue, Qingmei Shao, Gene L. Bidwell, III, and Junie P. Warrington. 2019. "Perinatal Micro-Bleeds and Neuroinflammation in E19 Rat Fetuses Exposed to Utero-Placental Ischemia" International Journal of Molecular Sciences 20, no. 16: 4051. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20164051

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop